From Bench to Body: Bridging the In Vitro–In Vivo Gap for Subcutaneous Drugs

Despite advances in drug development, achieving a true in vitro–in vivo correlation (IVIVC) for subcutaneous (SC) drugs remains difficult. However, innovative in vitro models like SCISSOR are helping bridge the gap, offering new insights into drug release and injection-site behavior. This infographic explores the current challenges and emerging solutions driving progress toward reliable IVIVC in SC drug development. Download now to explore how innovations are narrowing the gap to true IVIVC every day.

 From Bench to Body: Bridging the In Vitro–In Vivo Gap for Subcutaneous Drugs

Download Now

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.